Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shmuel Yaccoby

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Blood|July 15, 2009
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growthAngela Pennisi, Wen Ling, Xin Li, et al.
Molecular Cancer Therapeutics|March 6, 2008
Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myelomaErming Tian, Terry H Landowski, Owen W Stephens, et al.
Cancer Research|March 18, 2004
Cancer and the microenvironment: myeloma-osteoclast interactions as a modelShmuel Yaccoby, Michele J Wezeman, Aminah Henderson, et al.
BMC Cancer|November 8, 2015
Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrowRakesh Bam, Sharmin Khan, Wen Ling, et al.
Plos One|December 29, 2010
Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous boneAngela Pennisi, Wen Ling, Xin Li, et al.
Blood|July 2, 2002
Soluble syndecan-1 promotes growth of myeloma tumors in vivoYang Yang, Shmuel Yaccoby, Wei Liu, et al.
Cancer Cell|October 19, 2006
Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignanciesJing Yang, Jianfei Qian, Michele Wezeman, et al.
American Journal of Hematology|June 5, 2007
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patientsMaurizio Zangari, Dixie Esseltine, Federica Cavallo, et al.
Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.
Blood|July 26, 2014
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSarah K Johnson, James P Stewart, Rakesh Bam, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Blood|July 15, 2009
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growthAngela Pennisi, Wen Ling, Xin Li, et al.
Molecular Cancer Therapeutics|March 6, 2008
Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myelomaErming Tian, Terry H Landowski, Owen W Stephens, et al.
Cancer Research|March 18, 2004
Cancer and the microenvironment: myeloma-osteoclast interactions as a modelShmuel Yaccoby, Michele J Wezeman, Aminah Henderson, et al.
BMC Cancer|November 8, 2015
Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrowRakesh Bam, Sharmin Khan, Wen Ling, et al.
Plos One|December 29, 2010
Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous boneAngela Pennisi, Wen Ling, Xin Li, et al.
Blood|July 2, 2002
Soluble syndecan-1 promotes growth of myeloma tumors in vivoYang Yang, Shmuel Yaccoby, Wei Liu, et al.
Cancer Cell|October 19, 2006
Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignanciesJing Yang, Jianfei Qian, Michele Wezeman, et al.
American Journal of Hematology|June 5, 2007
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patientsMaurizio Zangari, Dixie Esseltine, Federica Cavallo, et al.
Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.
Blood|July 26, 2014
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSarah K Johnson, James P Stewart, Rakesh Bam, et al.
Pageof 7